Modelling transmission and control of the COVID-19 pandemic in Australia

Abstract

There is a continuing debate on relative benefits of various mitigation and suppression strategies aimed to control the spread of COVID-19. Here we report the results of agent-based modelling using a fine-grained computational simulation of the ongoing COVID-19 pandemic in Australia. This model is calibrated to match key characteristics of COVID-19 transmission. An important calibration outcome is the age-dependent fraction of symptomatic cases, with this fraction for children found to be one-fifth of such fraction for adults. We apply the model to compare several intervention strategies, including restrictions on international air travel, case isolation, home quarantine, social distancing with varying levels of compliance, and school closures. School closures are not found to bring decisive benefits unless coupled with high level of social distancing compliance. We report several trade-offs, and an important transition across the levels of social distancing compliance, in the range between 70% and 80% levels, with compliance at the 90% level found to control the disease within 13–14 weeks, when coupled with effective case isolation and international travel restrictions.

Full text

Its licence does not allow us to show the full text. Read it at PubMed Central:

References 67

1. 1.

   National Health Commission (NHC) of the People’s Republic of China. NHC daily reports. http://www.nhc.gov.cn/yjb/pzhgli/new_list.shtml (2020).

   Not in our library

2. 2.

   Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470-473.

   Not in our library10.1016/s0140-6736(20)30185-9 (opens in a new tab)

3. 3.

   WHO. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) (WHO, 2020).

   Not in our library

4. 4.

   The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Vital surveillances: the epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)—China, 2020. China CDC Weekly2, 113–122 (2020).

   Not in our library

5. 5.

   WHO. WHO Director-General’s opening remarks at the media briefing on COVID-19—11 March 2020 (2020). https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (2020).

   Not in our library

6. 6.
   Global socio-economic losses and environmental gains from the Coronavirus pandemic · 2020

   Corrected
7. 7.

   Longini IM, et al. Containing pandemic influenza at the source. Science. 2005;309:1083-1087.

   Not in our library10.1126/science.1115717 (opens in a new tab)

8. 8.

   Ferguson NM, et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature. 2005;437:209-214.

   Not in our library10.1038/nature04017 (opens in a new tab)

9. 9.

   Nsoesie EO, Beckman RJ, Marathe MV. Sensitivity analysis of an individual-based model for simulation of influenza epidemics. PLoS ONE. 2012;7:0045414.

   Not in our library10.1371/journal.pone.0045414 (opens in a new tab)

10. 10.
    A systematic review of studies on forecasting the dynamics of influenza outbreaks · 2013

    No notice
11. 11.

    Ferguson, N. M. et al. Imperial College COVID-19 Response Team. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Preprint at 10.25561/77482 (2020).

    Not in our library

12. 12.

    Halloran ME, Longini IM, Nizam A, Yang Y. Containing bioterrorist smallpox. Science. 2002;298:1428-1432.

    Not in our library10.1126/science.1074674 (opens in a new tab)

13. 13.

    Eubank S, et al. Modelling disease outbreaks in realistic urban social networks. Nature. 2004;429:180.

    Not in our library10.1038/nature02541 (opens in a new tab)

14. 14.

    Longini IM, Halloran ME, Nizam A, Yang Y. Containing pandemic influenza with antiviral agents. Am. J. Epidemiol. 2004;159:623-633.

    Not in our library10.1093/aje/kwh092 (opens in a new tab)

15. 15.

    Germann TC, Kadau K, Longini IM, Macken CA. Mitigation strategies for pandemic influenza in the United States. Proc. Natl Acad. Sci. USA. 2006;103:5935-5940.

    Not in our library10.1073/pnas.0601266103 (opens in a new tab)

16. 16.

    Barrett C, Bisset K, Leidig J, Marathe A, Marathe MV. An integrated modeling environment to study the co-evolution of networks, individual behavior and epidemics. AI Mag. 2010;31:75-87.

    Not in our library10.1609/aimag.v31i1.2283 (opens in a new tab)

17. 17.

    Balcan D, et al. Modeling the spatial spread of infectious diseases: the global epidemic and mobility computational model. J. Comput. Sci. 2010;1:132-145.

    Not in our library10.1016/j.jocs.2010.07.002 (opens in a new tab)

18. 18.
    FluTE, a Publicly Available Stochastic Influenza Epidemic Simulation Model · 2010

    No notice
19. 19.

    Cliff OM, et al. Investigating spatiotemporal dynamics and synchrony of influenza epidemics in Australia: an agent-based modelling approach. Simul. Model. Pract. Theory. 2018;87:412-431.

    Not in our library10.1016/j.simpat.2018.07.005 (opens in a new tab)

20. 20.

    Zachreson C, et al. Urbanization affects peak timing, prevalence, and bimodality of influenza pandemics in Australia: results of a census-calibrated model. Sci. Adv. 2018;4:eaau5294.

    Not in our library10.1126/sciadv.aau5294 (opens in a new tab)

21. 21.

    Harding N, Spinney RE, Prokopenko M. Phase transitions in spatial connectivity during influenza pandemics. Entropy. 2020;22:133.

    Not in our library10.3390/e22020133 (opens in a new tab)

22. 22.

    Zachreson C, Fair KM, Harding N, Prokopenko M. Interfering with influenza: nonlinear coupling of reactive and static mitigation strategies. J. R. Soc. Interface. 2020;17:20190728.

    Not in our library10.1098/rsif.2019.0728 (opens in a new tab)

23. 23.

    Efron, B. & Tibshirani, R. J. An Introduction to the Bootstrap, Vol. 57 (Chapman & Hall, New York, 1994).

    Not in our library

24. 24.

    Moss, R. et al. Modelling the impact of COVID-19 in Australia to inform transmission reducing measures and health system preparedness. medRxiv10.1101/2020.04.07.20056184 (2020).

    Not in our library10.3201/eid2612.202530 (opens in a new tab)

25. 25.

    Anderson RM, May RM. Vaccination and herd immunity to infectious diseases. Nature. 1985;318:323-329.

    Not in our library10.1038/318323a0 (opens in a new tab)

26. 26.

    Yeomans, J. M. Statistical Mechanics of Phase Transitions (Clarendon Press, 1992).

    Not in our library

27. 27.

    Newman ME, Watts DJ. Scaling and percolation in the small-world network model. Phys. Rev. E. 1999;60:7332.

    Not in our library10.1103/physreve.60.7332 (opens in a new tab)

28. 28.

    Newman ME. Spread of epidemic disease on networks. Phys. Rev. E. 2002;66:016128.

    Not in our library10.1103/physreve.66.016128 (opens in a new tab)

29. 29.

    Harding N, Nigmatullin R, Prokopenko M. Thermodynamic efficiency of contagions: a statistical mechanical analysis of the SIS epidemic model. Interface Focus. 2018;8:20180036.

    Not in our library10.1098/rsfs.2018.0036 (opens in a new tab)

30. 30.

    Harding N, Spinney RE, Prokopenko M. Population mobility induced phase separation in SIS epidemic and social dynamics. Sci. Rep. 2020;10:7646.

    Not in our library10.1038/s41598-020-64183-1 (opens in a new tab)

31. 31.

    Guisoni N, Loscar E, Albano E. Phase diagram and critical behavior of a forest-fire model in a gradient of immunity. Phys. Rev. E. 2011;83:011125.

    Not in our library10.1103/physreve.83.011125 (opens in a new tab)

32. 32.
    COVID-19 in 7780 pediatric patients: A systematic review · 2020

    Not checked
33. 33.

    Group of Eight (Go8) Australian Universities Taskforce. COVID-19 Roadmap to Recovery: A Report for the Nation (Group of Eight (Go8) Australian Universities Taskforce, 2020).

    Not in our library

34. 34.

    Cauchemez S, et al. Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza. Proc. Natl Acad. Sci. USA. 2011;108:2825-2830.

    Not in our library10.1073/pnas.1008895108 (opens in a new tab)

35. 35.

    Meyers LA, Newman M, Martin M, Schrag S. Applying network theory to epidemics: control measures for Mycoplasma pneumoniae outbreaks. Emerg. Infect. Dis. 2003;9:204.

    Not in our library10.3201/eid0902.020188 (opens in a new tab)

36. 36.

    Small M, Cavanagh D. Modelling strong control measures for epidemic propagation with networks—a COVID-19 case study. IEEE Access. 2020;8:109719-109731.

    Not in our library10.1109/access.2020.3001298 (opens in a new tab)

37. 37.

    Antia R, Regoes RR, Koella JC, Bergstrom CT. The role of evolution in the emergence of infectious diseases. Nature. 2003;426:658-661.

    Not in our library10.1038/nature02104 (opens in a new tab)

38. 38.
    Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions · 2020

    No notice
39. 39.

    Piraveenan M, Prokopenko M, Zomaya AY. Assortativeness and information in scale-free networks. Eur. Phys. J. B. 2009;67:291-300.

    Not in our library10.1140/epjb/e2008-00473-5 (opens in a new tab)

40. 40.

    Cliff O, et al. Network properties of Salmonella epidemics. Sci. Rep. 2019;9:6159.

    Not in our library10.1038/s41598-019-42582-3 (opens in a new tab)

41. 41.

    Rockett, R. J. et al. Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent based modelling. Nat. Med.10.1038/s41591-020-1000-7 (2020).

    Not in our library10.1038/s41591-020-1000-7 (opens in a new tab)

42. 42.
    Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases · 2008

    No notice
43. 43.

    Chang SL, Piraveenan M, Pattison P, Prokopenko M. Game theoretic modelling of infectious disease dynamics and intervention methods: a review. J. Biol. Dyn. 2020;14:57-89.

    Not in our library10.1080/17513758.2020.1720322 (opens in a new tab)

44. 44.

    Gros, C., Valenti, R., Schneider, L., Valenti, K. & Gros, D. Containment efficiency and control strategies for the corona pandemic costs. arXiv:2004.00493 (2020).

    Not in our library10.1038/s41598-021-86072-x (opens in a new tab)

45. 45.

    Walker, P. G. T. et al. Imperial College COVID-19 Response Team. The global impact of COVID-19 and strategies for mitigation and suppression. Science.10.1126/science.abc0035 (2020).

    Not in our library

46. 46.

    Dignum F, et al. Analysing the combined health, social and economic impacts of the corovanvirus pandemic using agent-based social simulation. Minds Mach. 2020;30:177-194.

    Not in our library10.1007/s11023-020-09527-6 (opens in a new tab)

47. 47.

    Fair KM, Zachreson C, Prokopenko M. Creating a surrogate commuter network from Australian Bureau of Statistics census data. Sci. Data. 2019;6:150.

    Not in our library10.1038/s41597-019-0137-z (opens in a new tab)

48. 48.

    Guan, W.-j. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med.382, 1708–1720 (2020).

    Not in our library10.1056/nejmoa2002032 (opens in a new tab)

49. 49.
    Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2) · 2020

    No notice
50. 50.
    Early dynamics of transmission and control of COVID-19: a mathematical modelling study · 2020

    Corrected
51. 51.

    Liu, Y., Gayle, A. A., Wilder-Smith, A. & Rocklöv, J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J. Travel Med.27, taaa021 (2020).

    Not in our library10.1093/jtm/taaa021 (opens in a new tab)

52. 52.

    Li, Q. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N. Engl. J. Med.382, 1199–1207 (2020).

    Not in our library10.1056/nejmoa2001316 (opens in a new tab)

53. 53.

    Huang, H. et al. Epidemic features and control of 2019 novel coronavirus pneumonia in Wenzhou, China. Preprints with Lancet (2020).

    Not in our library

54. 54.

    Shim E, Tariq A, Choi W, Lee Y, Chowell G. Transmission potential and severity of COVID-19 in South Korea. Int. J. Infect. Dis. 2020;93:339-344.

    Not in our library10.1016/j.ijid.2020.03.031 (opens in a new tab)

55. 55.

    Mizumoto, K., Omori, R. & Nishiura, H. Age specificity of cases and attack rate of novel coronavirus disease (COVID-19). medRxiv10.1101/2020.03.09.20033142 (2020).

    Not in our library10.1016/j.ijid.2020.04.080 (opens in a new tab)

56. 56.
    Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data · 2020

    No notice
57. 57.

    Nishiura, H. et al. Estimation of the asymptomatic ratio of novel coronavirus infections (covid-19). Int. J. Infect. Dis.10.1016/j.ijid.2020.03.020 (2020).

    Not in our library10.1016/j.ijid.2020.03.020 (opens in a new tab)

58. 58.
    Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 · 2020

    Corrected
59. 59.

    Bi, Q. et al. Epidemiology and transmission of COVID-19 in Shenzhen China: analysis of 391 cases and 1,286 of their close contacts. medRxiv10.1101/2020.03.03.20028423 (2020).

    Not in our library10.1016/s1473-3099(20)30287-5 (opens in a new tab)

60. 60.

    Dong, Y. et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics10.1542/peds.2020-0702 (2020).

    Not in our library

61. 61.

    Cacuci, D. G. Sensitivity and Uncertainty Analysis: Theory, Vol. 1 (Chapman & Hall/CRC, 2003).

    Not in our library

62. 62.

    Morris MD. Factorial sampling plans for preliminary computational experiments. Technometrics. 1991;33:161-174.

    Not in our library10.1080/00401706.1991.10484804 (opens in a new tab)

63. 63.

    Wu J, Dhingra R, Gambhir M, Remais JV. Sensitivity analysis of infectious disease models: methods, advances and their application. J. R. Soc. Interface. 2013;10:20121018.

    Not in our library10.1098/rsif.2012.1018 (opens in a new tab)

64. 64.

    Johns Hopkins University. Coronavirus COVID-19 Global Cases (Johns Hopkins University, Baltimore, 2020).

    Not in our library

65. 65.
    Exit strategies: optimising feasible surveillance for detection, elimination, and ongoing prevention of COVID-19 community transmission · 2021

    Not checked
66. 66.

    Australian Bureau of Statistics. Household Impacts of COVID-19 Survey, 1–6 Apr 2020 (Australian Bureau of Statistics, 2020).

    Not in our library

67. 67.

    Wikipedia Contributors. 2019–20 coronavirus pandemic in mainland China; 2020 coronavirus pandemic in Wikipedia; nation: Australia; France; Germany; Iran; Italy; South Korea; Spain; the United States. The Free Encyclopedia (2020).

    Not in our library

Cited by papers we hold 4

• OpenABM-Covid19—An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing · 2021
  No notice
• Generalized logistic growth modeling of the COVID-19 outbreak: comparing the dynamics in the 29 provinces in China and in the rest of the world · 2020
  No notice
• Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions · 2020
  No notice
• Dynamic interventions to control COVID-19 pandemic: a multivariate prediction modelling study comparing 16 worldwide countries · 2020
  No notice

Questions about this paper

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.